세계 죽종절제 기기 시장 규모는 2022년 약 8억 9,030만 달러로 2023년 9억 6,241만 달러에서 2031년 17억 9,460만 달러에 달할 것으로 예상되며, 예측 기간(2024-2031년) 동안 8.1%의 CAGR을 기록할 것으로 예상됩니다.
죽종절제 기기 세계 시장은 노인 인구의 증가, 생활습관의 변화, 건강에 해로운 식습관으로 인해 점점 더 널리 퍼지고 있는 심혈관질환의 발생률 증가가 주요 요인으로 작용하여 크게 성장할 것으로 예상됩니다. 이러한 건강에 대한 관심이 높아지면서 더 많은 환자들이 효과적인 치료법을 찾고 있으며, 이는 죽상동맥경화증 치료 장비에 대한 수요를 증가시킬 것으로 예상됩니다. 또한, 의료 전문가와 환자들이 심혈관 중재에 대한 최소침습적 옵션을 선호함에 따라 최소침습 수술 트렌드는 의료 전문가와 환자 모두에게 새로운 길을 제시하며 죽종절제 기기 공급자에게 새로운 길을 제시하고 있습니다. 또한, 의료 연구 및 개발에 대한 지속적인 투자는 죽종절제 기기의 기술 발전을 촉진하고 이 분야에서 더 많은 비즈니스 기회를 창출할 것으로 예상됩니다. 하지만, 죽종절제술 및 기기와 관련된 높은 비용, 수술 중 합병증의 잠재적 위험성, 대체 치료 옵션의 가용성 등의 문제들이 장기적으로 시장 확대에 걸림돌이 될 수 있습니다. 그럼에도 불구하고, 수요 증가, 기술 혁신, 최소침습적 솔루션에 대한 선호도 변화 등이 복합적으로 작용하여 향후 몇 년 동안 죽종절제 기기 공급업체들은 이 성장 시장에서 수익을 창출할 수 있을 것으로 보입니다.
Global Atherectomy Devices Market size was valued at around USD 890.30 million in 2022 and is expected to rise from USD 962.41 million in 2023 to reach a value of USD 1794.60 million by 2031, at a CAGR of 8.1% over the forecast period (2024-2031).
The global market for atherectomy devices is poised for significant growth, driven largely by the escalating incidence of cardiovascular diseases, which are increasingly prevalent due to a growing elderly population, poor lifestyle choices, and unhealthy dietary habits. This rising health concern is expected to bolster the demand for atherectomy devices as more patients seek effective treatment options. Additionally, the trend towards minimally invasive procedures is gaining traction, presenting new avenues for providers of atherectomy devices as healthcare professionals and patients alike favor less invasive options for cardiovascular interventions. Furthermore, ongoing investments in medical research and development are anticipated to propel technological advancements in atherectomy devices, creating even more opportunities in this sector. However, the market faces challenges, including the high costs associated with atherectomy procedures and devices, potential risks of complications during operations, and the availability of alternative treatment options, which may hinder market expansion in the long term. Nonetheless, the confluence of increasing demand, technological innovations, and a shifting preference towards minimally invasive solutions positions atherectomy device providers to capitalize on this growing market in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atherectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Atherectomy Devices Market Segmental Analysis
Global Atherectomy Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices, and Others. Based on Application, the market is segmented into Peripheral Vascular, Cardiovascular, and Neurovascular. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Atherectomy Devices Market
The global atherectomy devices market is significantly driven by the aging population, which is increasingly at risk for cardiovascular complications like arterial blockages. As older individuals often experience a higher prevalence of such conditions, the demand for effective treatment options is rising. Atherectomy devices, essential for addressing these disorders, are gaining traction due to a growing preference for minimally invasive procedures among geriatric patients. This trend not only enhances patient outcomes but also aligns with the broader shift towards less invasive, safer medical interventions, thereby propelling the market's expansion and adoption in cardiovascular care strategies worldwide.
Restraints in the Global Atherectomy Devices Market
One of the significant market restraints for the global atherectomy devices market is the inherent risk of complications associated with atherectomy procedures. The complexity of these procedures, influenced by numerous variables such as patient anatomy, operator skill, and device selection, presents challenges in ensuring optimal outcomes. The fear of potential complications, including vessel perforation, dissection, or embolization, can deter both healthcare providers and patients from opting for atherectomy as a treatment option. Consequently, the apprehension surrounding these risks may hinder the growth of atherectomy device sales, as medical professionals may seek alternative treatment modalities perceived as less risky.
Market Trends of the Global Atherectomy Devices Market
The Global Atherectomy Devices market is witnessing a notable trend towards the integration of advanced technologies, particularly artificial intelligence (AI) and machine learning (ML). Manufacturers are increasingly focusing on these innovations to enhance the functionality and precision of their devices, ultimately improving patient outcomes in vascular interventions. By harnessing AI and ML, companies can streamline both the development processes and clinical deployment of atherectomy systems, thereby maximizing their operational efficiency and market reach. This technological shift is expected to drive competitive advantage in the marketplace, positioning manufacturers at the forefront of the evolving landscape of cardiovascular treatment solutions.